Eliem Therapeutics, Inc. Competitors
| Symbol | Share Price | Market Cap | P/E Ratio | Employee Count |
|---|---|---|---|---|
ANTX
AN2 Therapeutics, Inc. |
$1.07 | $32.29 M | -0.71 | 22 |
IPSC
Century Therapeutics, Inc. |
$0.55 | $47.51 M | -2.04 | 140 |
ACRV
Acrivon Therapeutics, Inc. Common Stock |
$1.14 | $35.59 M | -0.53 | 75 |
AVTE
Aerovate Therapeutics, Inc. |
$7.13 | $77.68 M | -0.05 | 4 |
MNOV
MediciNova, Inc. |
$1.43 | $69.65 M | -6.17 | 13 |
PHVS
Pharvaris N.V. |
$16.69 | $912.21 M | -5.23 | 108 |
PEPG
PepGen Inc. |
$1.46 | $54.97 M | -0.54 | 79 |
PMVP
PMV Pharmaceuticals, Inc. |
$0.88 | $46.41 M | -0.76 | 47 |
CYT
Cyteir Therapeutics, Inc. |
$0.00 | $108.71 M | -3.25 | 46 |
RZLT
Rezolute, Inc. |
$4.26 | $356.19 M | -3.59 | 64 |
ADAG
Adagene Inc. |
$2.07 | $78.01 M | -2.8 | 138 |
STTK
Shattuck Labs, Inc. |
$1.01 | $51.50 M | -0.77 | 44 |
HCWB
HCW Biologics Inc. |
$7.20 | $19.36 M | -0.32 | 36 |
ANEB
Anebulo Pharmaceuticals, Inc. |
$1.02 | $43.55 M | -4.24 | 2 |
CSBR
Champions Oncology, Inc. |
$5.98 | $82.68 M | 13.29 | 210 |
MOLN
Molecular Partners AG |
$3.79 | $131.92 M | -1.73 | 158 |
PRDS
Pardes Biosciences, Inc. |
$0.00 | $135.19 M | -1.7 | 57 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
